RadhaMRaoMD

PubMed

• Inhibition of histone deacetylase (HDAC) 6 sensitizes human leukemia and breast cancer cells to antagonists of heat shock protein (hsp) 90 and/or bortezomib (BZ).
  Bhalla KN, Bali P, Balasis M, Fiskus W, Pranpat M, Rocha K, Rao RM, Kumaraswamy S, Atadja P> ;J. Clin. Oncol.. 2006-06-20
• Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
  Pockaj, B.A., Gallagher, J.G., Loprinzi, C.L., Stella, P.J., Barton, D.L., Sloan, J.A., Lavasseur, B.I., Rao, R.M., Fitch, T.R., Rowland, K.M., Novotny, P.J., Flynn, P...> ;J Clin Oncol. 2006 Jun 20
• A phase I/II NCCTG trial of escalating doses of twice daily thoracic radiation therapy (TRT) in limited-stage small cell lung cancer (LSCLC).
  Garces YI, Okuno SH, Schild SE, Mandrekar SJ, Mailliard JA, Kahanic SP, Rao RM, Moore DF, Kozelsky TF, Jett JR> ;J. Clin. Oncol.. 2005-06-01
• Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study.
  Sparano JA, Hu P, Rao RM, Falkson CI, Wolff AC, Wood WC> ;J. Clin. Oncol.. 1999-12-01
• Join now to see all